Suda K - Search Results

1

A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation.

Shimizu R, Suda K, Takemoto T, Fukuda S, Chiba M, Shimoji M, Soh J, Mitsudomi T, Tsutani Y. Shimizu R, et al. Among authors: suda k. Surg Case Rep. 2024 Feb 28;10(1):49. doi: 10.1186/s40792-024-01851-8. Surg Case Rep. 2024. PMID: 38416260 Free PMC article.

2

EGFR T790M mutation: a double role in lung cancer cell survival?

Suda K, Onozato R, Yatabe Y, Mitsudomi T. Suda K, et al. J Thorac Oncol. 2009 Jan;4(1):1-4. doi: 10.1097/JTO.0b013e3181913c9f. J Thorac Oncol. 2009. PMID: 19096299 Free article. Review.

3

Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.

Katayama T, Shimizu J, Suda K, Onozato R, Fukui T, Ito S, Hatooka S, Sueda T, Hida T, Yatabe Y, Mitsudomi T. Katayama T, et al. Among authors: suda k. J Thorac Oncol. 2009 Nov;4(11):1415-9. doi: 10.1097/JTO.0b013e3181b62572. J Thorac Oncol. 2009. PMID: 19692934 Free article.

4

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.

Suda K, Tomizawa K, Mitsudomi T. Suda K, et al. Cancer Metastasis Rev. 2010 Mar;29(1):49-60. doi: 10.1007/s10555-010-9209-4. Cancer Metastasis Rev. 2010. PMID: 20108024 Review.

5

Analysis of ERBB4 mutations and expression in japanese patients with lung cancer.

Tomizawa K, Suda K, Onozato R, Kuwano H, Yatabe Y, Mitsudomi T. Tomizawa K, et al. Among authors: suda k. J Thorac Oncol. 2010 Nov;5(11):1859-61. doi: 10.1097/JTO.0b013e3181f1c433. J Thorac Oncol. 2010. PMID: 20975381 Free article.

6

Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.

Suda K, Murakami I, Katayama T, Tomizawa K, Osada H, Sekido Y, Maehara Y, Yatabe Y, Mitsudomi T. Suda K, et al. Clin Cancer Res. 2010 Nov 15;16(22):5489-98. doi: 10.1158/1078-0432.CCR-10-1371. Epub 2010 Nov 9. Clin Cancer Res. 2010. PMID: 21062933

7

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.

Tomizawa K, Suda K, Onozato R, Kosaka T, Endoh H, Sekido Y, Shigematsu H, Kuwano H, Yatabe Y, Mitsudomi T. Tomizawa K, et al. Among authors: suda k. Lung Cancer. 2011 Oct;74(1):139-44. doi: 10.1016/j.lungcan.2011.01.014. Epub 2011 Feb 25. Lung Cancer. 2011. PMID: 21353324

8

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.

Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T. Suda K, et al. J Thorac Oncol. 2011 Jul;6(7):1152-61. doi: 10.1097/JTO.0b013e318216ee52. J Thorac Oncol. 2011. PMID: 21597390 Free article.

9

Lung cancers unrelated to smoking: characterized by single oncogene addiction?

Suda K, Tomizawa K, Yatabe Y, Mitsudomi T. Suda K, et al. Int J Clin Oncol. 2011 Aug;16(4):294-305. doi: 10.1007/s10147-011-0262-y. Epub 2011 Jun 8. Int J Clin Oncol. 2011. PMID: 21655907

10

Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation.

Suda K, Tomizawa K, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T. Suda K, et al. Lung Cancer. 2012 Jun;76(3):292-9. doi: 10.1016/j.lungcan.2011.11.007. Epub 2011 Nov 30. Lung Cancer. 2012. PMID: 22133747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,529 results

Search Page

Filters